<DOC>
	<DOCNO>NCT00547625</DOCNO>
	<brief_summary>Study look safety effectiveness different dos tadalafil prostate relate genital/urinary tract problem .</brief_summary>
	<brief_title>Study Determine Safety Effectiveness Tadalafil Prostate Related Sex Organ/Urinary Tract Problems</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>6 month history low urinary tract symptom either obstructive and/or irritative secondary prostate relate problem diagnosed urologist . Stopped use treatment least four week prior study agree use treatment study . Meet required prostate symptom score urine flow rate . Serum prostate specific antigen ( PSA ) great 10 ( 4 10 , inclusive , without negative biopsy w/in last 6 month . Prostate removal various pelvic surgery . Neurological disease condition know affect bladder . Clinical evidence prostate cancer , urinary tract inflammation infection , include prostatitis . Have take medication nitrate , finasteride , dutasteride within year .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>